Evidence map›Paper›PMID 26774674›Full record

ArticleFree radical biology & medicine2016

Oxidized LDL induced extracellular trap formation in human neutrophils via TLR-PKC-IRAK-MAPK and NADPH-oxidase activation.

Deepika Awasthi, Sheela Nagarkoti, Amit Kumar, Megha Dubey, Abhishek Kumar Singh, Priya Pathak, Tulika Chandra, Manoj Kumar Barthwal, Madhu Dikshit

Abstract read
PubMed Publisher
In one paragraph

Article in Free radical biology & medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 102 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
102citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

102 citing papers in PubMed, 2 syntheses or guidelines pooled it, 169 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Indole-3-carboxaldehyde fromGut microbes · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Metabolic Control of Immunity-Unveiling Neutrophil Mechanisms.Advances in experimental medicine and biology · 2026
    Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Breast cancer induces CD62LCell discovery · 2025
    Article
  19. Review
  20. Article

42 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Deepika AwasthiPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Sheela NagarkotiPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Amit KumarPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Megha DubeyPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Abhishek Kumar SinghPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Priya PathakPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Tulika ChandraDepartment of Transfusion Medicine, King George's Medical University, Lucknow, India.
Manoj Kumar BarthwalPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India.
Madhu DikshitPharmacology Division, CSIR-Central Drug Research Institute, Lucknow, India. Electronic address: madhu_dikshit@cdri.res.in.
Central Drug Research Institute · INKing George's Medical University · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neutrophil extracellular traps (NETs) formation was initially linked with host defence and extracellular killing of pathogens. However, recent studies have highlighted their inflammatory potential. Oxidized low density lipoprotein (oxLDL) has been implicated as an independent risk factor in various acute or chronic inflammatory diseases including systemic inflammatory response syndrome (SIRS). In the present study we investigated effect of oxLDL on NETs formation and elucidated the underlying signalling mechanism. Treatment of oxLDL to adhered PMNs led to a time and concentration dependent ROS generation and NETs formation. OxLDL induced free radical formation and NETs release were significantly prevented in presence of NADPH oxidase (NOX) inhibitors suggesting role of NOX activation in oxLDL induced NETs release. Blocking of both toll like receptor (TLR)-2 and 6 significantly reduced oxLDL induced NETs formation indicating requirement of both the receptors. We further identified Protein kinase C (PKC), Interleukin-1 receptor associated kinase (IRAKs), mitogen-activated protein kinase (MAPK) pathway as downstream intracellular signalling mediators involved in oxLDL induced NETs formation. OxLDL components such as oxidized phospholipids (lysophosphatidylcholine (LPC) and oxidized 1-palmitoyl-2-arachidonyl-sn-glycero-3-phosphorylcholine (oxPAPC)) were most potent NETs inducers and might be crucial for oxLDL mediating NETs release. Other components like, oxysterols, malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE) were however less potent as compared to oxidized phospholipids. This study thus demonstrates for the first time that treatment of human PMNs with oxLDL or its various oxidized phopholipid component mediated NETs release, implying their role in the pathogenesis of inflammatory diseases such as SIRS.

Indexed as

AldehydesExtracellular TrapsHumansInterleukin-1 Receptor-Associated KinasesLipoproteins, LDLMalondialdehydeNADPH OxidasesNeutrophilsOxidation-ReductionProtein Kinase CReactive Oxygen SpeciesSignal TransductionSystemic Inflammatory Response SyndromeToll-Like Receptor 24-hydroxy-2-nonenalAldehydesInterleukin-1 Receptor-Associated KinasesLipoproteins, LDLMalondialdehydeNADPH Oxidasesoxidized low density lipoproteinProtein Kinase CReactive Oxygen SpeciesTLR2 protein, humanToll-Like Receptor 2NADPH oxidaseNeutrophil extracellular trapsOxidized low density lipoproteinOxidized phospholipidsSystemic inflammatory response syndrome

Identifiers

PMID26774674
OpenAlexW2270530482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.